We are live on ! Find out more
FCC

Flower City Capital Portfolio holdings

AUM $227M
1-Year Est. Return 23.31%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+23.31%
3 Year Est. Return
+60.67%
5 Year Est. Return
10 Year Est. Return
AUM
$186M
AUM Growth
+$16.4M
Cap. Flow
+$3.49M
Cap. Flow %
1.88%
Top 10 Hldgs %
91.35%
Holding
44
New
5
Increased
6
Reduced
17
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 3.96%
2 Consumer Discretionary 0.78%
3 Communication Services 0.6%
4 Energy 0.52%
5 Financials 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$956B
$382K 0.21%
1,211
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.35T
$343K 0.18%
1,410
TPL icon
28
Texas Pacific Land
TPL
$24.2B
$342K 0.18%
1,098
VB icon
29
Vanguard Morningstar Small-Cap ETF
VB
$82.5B
$337K 0.18%
1,318
-28
-2% -$6.94K
IBM icon
30
IBM
IBM
$223B
$331K 0.18%
1,174
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.14T
$320K 0.17%
637
IYW icon
32
iShares US Technology ETF
IYW
$25.3B
$317K 0.17%
1,620
SCHA icon
33
Schwab U.S Small- Cap ETF
SCHA
$23B
$244K 0.13%
8,732
-2
-0% -$53
SCHE icon
34
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$243K 0.13%
7,271
VO icon
35
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$241K 0.13%
3,272
WPM icon
36
Wheaton Precious Metals
WPM
$60.6B
$238K 0.13%
+2,127
New +$208K
GRVY
37
GRAVITY
GRVY
$481M
$224K 0.12%
3,500
-1,000
-22% -$64.1K
AON icon
38
Aon
AON
$75.7B
$219K 0.12%
613
-161
-21% -$58.2K
IMRX icon
39
Immuneering
IMRX
$293M
$205K 0.11%
29,229
-2,800
-9% -$14.5K
GEV icon
40
GE Vernova
GEV
$264B
$202K 0.11%
+329
New +$199K
KURA icon
41
Kura Oncology
KURA
$874M
$88.5K 0.05%
10,000
PGEN icon
42
Precigen
PGEN
$2.51B
$65.8K 0.04%
+20,000
New +$56.5K
OTLK icon
43
Outlook Therapeutics
OTLK
$215M
$21.2K 0.01%
+20,000
New +$34.6K
REGN icon
44
Regeneron Pharmaceuticals
REGN
$83.2B
-500
Closed -$263K

Similar funds

Flower City Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Flower City Capital held 44 positions worth $186M, up 9.7% from $170M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Flower City Capital's Q3 2025 filing shows 5 new, 6 increased, 17 reduced and 1 closed positions. Its largest new stake was Chevron: 4,044 shares worth $628K. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.03M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 3.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Flower City Capital's largest Q3 2025 buy was Chevron: 4,044 shares worth $628K.
  • Flower City Capital added most to Vanguard Russell 1000 ETF in Q3 2025, an estimated $3M increase.
  • Flower City Capital's biggest Q3 2025 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $1.03M.
  • Flower City Capital fully exited Regeneron Pharmaceuticals in Q3 2025, selling an estimated $263K.
  • Flower City Capital's ten largest holdings make up 91% of its $186M portfolio in Q3 2025.
  • Flower City Capital opened 5 new positions and closed 1 in Q3 2025.
  • Flower City Capital's portfolio value rose 9.7% quarter-over-quarter to $186M.

Based on Flower City Capital's 13F filing for Q3 2025, filed 8 Oct 2025.